Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Roche Holding Ag (RHHBY)
Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg
6/8/2026 2:50:09 AM
Nurix Therapeutics Partners With Roche On Bexobrutinib Development
6/8/2026 1:09:05 AM
Roche Develops Ebola PCR Test In Six Days Amid Bundibugyo Outbreak
6/4/2026 11:13:50 PM
Roche Develops Rapid PCR Test To Detect Rare Ebola Bundibugyo Virus
6/4/2026 9:05:46 PM
FDA Grants Priority Review For Roche's NDA For Giredestrant In Breast Cancer
6/2/2026 7:41:57 AM
Roche Announces FDA's Filing Acceptance Under Priority Review For Giredestrant
6/2/2026 1:41:06 AM
Roche's Giredestrant NDA Accepted For Priority Review In U.S. Breast Cancer Treatment
6/2/2026 1:15:27 AM
Genentech Presents Updated Clinical Results Of Enicepatide And Petrelintide At ADA 2026
6/1/2026 10:33:39 AM
Genentech Showcases Breakthrough Obesity Data At ADA 2026
6/1/2026 1:05:53 AM
Roche Launches Liver Disease Panel To Help Clinicians Identify Risk Earlier
5/27/2026 6:10:52 AM
Roche Unveils Certified Liver Disease Panel To Advance Chronic Care Management
5/27/2026 5:45:07 AM
Genentech To Present New Data At ASCO 2026
5/19/2026 1:08:19 AM
Weekly Buzz:FDA Clears Tab-cel Path, Arvinas Wins PROTAC Nod, Novartis Cuts Jobs, Roche Buys PathAI
5/8/2026 8:17:14 AM
Roche Enters $750 Mln Merger Deal To Acquire PathAI To Expand AI-Driven Diagnostics
5/7/2026 2:56:09 AM
Roche Enters Merger Deal To Acquire PathAI, To Bolster AI-Driven Diagnostics
5/7/2026 2:41:14 AM
Roche To Showcase Broad Ophthalmology Data Portfolio At ARVO 2026, Today
5/4/2026 4:26:25 AM
Roche Q1 Sales Down; Sees Full-Year Sales Growth At Constant Exchange Rates
4/23/2026 1:42:19 AM
Roche Q1 Sales CHF 14.722 Bln Vs. CHF 15.440 Bln Last Year
4/23/2026 1:14:00 AM
Roche's ENSPRYNG Cuts Relapse Risk In Rare Neurological Disease
4/22/2026 5:36:55 AM
Genentech's Fenebrutinib Slashes Relapses By Over 50% In RMS , But Safety Signals Cast A Shadow
4/22/2026 2:35:41 AM
1
2
Next
»